Pure Global

Stress and Congestive Heart Failure - Trial NCT04551560

Access comprehensive clinical trial information for NCT04551560 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Recruiting. The study focuses on Congestive Heart Failure. Target enrollment is 112 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04551560
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT04551560
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Stress and Congestive Heart Failure

Study Focus

Congestive Heart Failure

Mental Stress

Interventional

other

Sponsor & Location

Yale University

New Haven, United States of America

Timeline & Enrollment

N/A

Oct 07, 2020

Jun 30, 2025

112 participants

Primary Outcome

Pulmonary Artery Pressure

Summary

The purpose of this study is to investigate whether acute stress can precipitate congestive
 heart failure (CHF) exacerbation in patients with CHF.

ICD-10 Classifications

Congestive heart failure
Heart failure
Hypertensive heart disease with (congestive) heart failure
Hypertensive heart and renal disease with (congestive) heart failure
Heart failure, unspecified

Data Source

ClinicalTrials.gov

NCT04551560

Non-Device Trial